These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22202123)

  • 41. Generation and characterization of an attenuated mutant in a response regulator gene of Francisella tularensis live vaccine strain (LVS).
    Sammons-Jackson WL; McClelland K; Manch-Citron JN; Metzger DW; Bakshi CS; Garcia E; Rasley A; Anderson BE
    DNA Cell Biol; 2008 Jul; 27(7):387-403. PubMed ID: 18613792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors.
    Pierini LM
    Cell Microbiol; 2006 Aug; 8(8):1361-70. PubMed ID: 16882038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.
    Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A
    Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison.
    Rohmer L; Brittnacher M; Svensson K; Buckley D; Haugen E; Zhou Y; Chang J; Levy R; Hayden H; Forsman M; Olson M; Johansson A; Kaul R; Miller SI
    Infect Immun; 2006 Dec; 74(12):6895-906. PubMed ID: 17000723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular fate of Francisella tularensis within arthropod-derived cells.
    Santic M; Akimana C; Asare R; Kouokam JC; Atay S; Kwaik YA
    Environ Microbiol; 2009 Jun; 11(6):1473-81. PubMed ID: 19220402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uptake and intracellular fate of Francisella tularensis in human macrophages.
    Clemens DL; Horwitz MA
    Ann N Y Acad Sci; 2007 Jun; 1105():160-86. PubMed ID: 17435118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.
    Cong Y; Yu JJ; Guentzel MN; Berton MT; Seshu J; Klose KE; Arulanandam BP
    Vaccine; 2009 Sep; 27(41):5554-61. PubMed ID: 19651173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural IgM mediates complement-dependent uptake of Francisella tularensis by human neutrophils via complement receptors 1 and 3 in nonimmune serum.
    Schwartz JT; Barker JH; Long ME; Kaufman J; McCracken J; Allen LA
    J Immunol; 2012 Sep; 189(6):3064-77. PubMed ID: 22888138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The reduced genome of the Francisella tularensis live vaccine strain (LVS) encodes two iron acquisition systems essential for optimal growth and virulence.
    Pérez NM; Ramakrishnan G
    PLoS One; 2014; 9(4):e93558. PubMed ID: 24695402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acquisition of the vacuolar ATPase proton pump and phagosome acidification are essential for escape of Francisella tularensis into the macrophage cytosol.
    Santic M; Asare R; Skrobonja I; Jones S; Abu Kwaik Y
    Infect Immun; 2008 Jun; 76(6):2671-7. PubMed ID: 18390995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Francisella tularensis pathogenicity island protein IglC and its regulator MglA are essential for modulating phagosome biogenesis and subsequent bacterial escape into the cytoplasm.
    Santic M; Molmeret M; Klose KE; Jones S; Kwaik YA
    Cell Microbiol; 2005 Jul; 7(7):969-79. PubMed ID: 15953029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Francisella O-antigen mediates survival in the macrophage cytosol via autophagy avoidance.
    Case ED; Chong A; Wehrly TD; Hansen B; Child R; Hwang S; Virgin HW; Celli J
    Cell Microbiol; 2014 Jun; 16(6):862-77. PubMed ID: 24286610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis.
    Geier H; Celli J
    Infect Immun; 2011 Jun; 79(6):2204-14. PubMed ID: 21422184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IglG and IglI of the Francisella pathogenicity island are important virulence determinants of Francisella tularensis LVS.
    Bröms JE; Lavander M; Meyer L; Sjöstedt A
    Infect Immun; 2011 Sep; 79(9):3683-96. PubMed ID: 21690239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.
    Pechous RD; McCarthy TR; Mohapatra NP; Soni S; Penoske RM; Salzman NH; Frank DW; Gunn JS; Zahrt TC
    PLoS One; 2008 Jun; 3(6):e2487. PubMed ID: 18575611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions of Francisella tularensis with Alveolar Type II Epithelial Cells and the Murine Respiratory Epithelium.
    Faron M; Fletcher JR; Rasmussen JA; Apicella MA; Jones BD
    PLoS One; 2015; 10(5):e0127458. PubMed ID: 26010977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of virulence factors in Francisella tularensis determines human macrophage responses.
    Carlson PE; Carroll JA; O'Dee DM; Nau GJ
    Microb Pathog; 2007; 42(5-6):204-14. PubMed ID: 17369012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. OpiA, a Type Six Secretion System Substrate, Localizes to the Cell Pole and Plays a Role in Bacterial Growth and Viability in
    Cantlay S; Haggerty K; Horzempa J
    J Bacteriol; 2020 Jun; 202(14):. PubMed ID: 32366588
    [No Abstract]   [Full Text] [Related]  

  • 59. Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.
    Sebastian S; Pinkham JT; Lynch JG; Ross RA; Reinap B; Blalock LT; Conlan JW; Kasper DL
    Vaccine; 2009 Jan; 27(4):597-605. PubMed ID: 19022323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.